Clinical trials in La Louviere – page 39

1 401 clinical trials in La Louviere, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

La Louviere at a glance

1 401

clinical trials

Research sites1

Quick filters

1 401 trials in La Louviere

Open in trial search

Acute myeloid leukaemia+1

Recruiting

Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Registered drugNo placebo

Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ciclosporin
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Generalised tonic-clonic seizure+1

Recruiting

Study on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures

InvestigationalNo placebo

Study on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Sponsor:Xenon Pharmaceuticals Inc.

Contact Research Centre

Interstitial lung disease

Recruiting

Study on Long-Term Safety of Inhaled Treprostinil for Patients with Fibrotic Lung Disease

InvestigationalNo placebo

Study on Long-Term Safety of Inhaled Treprostinil for Patients with Fibrotic Lung Disease

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Treprostinil
Sponsor:United Therapeutics Corp.

Contact Research Centre

Pulmonary embolism

Recruiting

Study on Monitoring vs. Rivaroxaban for Patients with Low-Risk Isolated Subsegmental Pulmonary Embolism

Registered drug

Study on Monitoring vs. Rivaroxaban for Patients with Low-Risk Isolated Subsegmental Pulmonary Embolism

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Rivaroxaban
Sponsor:Insel Gruppe AG

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Gemtuzumab Ozogamicin and a Drug Combination

Registered drugNo placebo

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Gemtuzumab Ozogamicin and a Drug Combination

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years
Substances:Cytarabine
Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Contact Research Centre

Mucopolysaccharidosis II

Recruiting

Study on Long-Term Safety and Effects of DNL310 for Patients with Mucopolysaccharidosis Type II (MPS II)

InvestigationalNo placebo

Study on Long-Term Safety and Effects of DNL310 for Patients with Mucopolysaccharidosis Type II (MPS II)

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years
Sponsor:Denali Therapeutics Inc.

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Study on Conditioning Treatments with Busulfan, Clofarabine, and Fludarabine for Children with Acute Myeloid Leukemia Undergoing Stem Cell Transplantation

Registered drugNo placebo

Study on Conditioning Treatments with Busulfan, Clofarabine, and Fludarabine for Children with Acute Myeloid Leukemia Undergoing Stem Cell Transplantation

Registered drugNo placebo

Belgium

Participants:0–17 years
Substances:Busulfan
Sponsor:Vaestra Goetalandsregionen

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Recruiting

Study on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse

Registered drugNo placebo

Study on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:European Organisation For Research And Treatment Of Cancer

Contact Research Centre

Triple negative breast cancer

Recruiting

Study of Bicalutamide and Abemaciclib for Patients with Advanced Androgen Receptor Positive Triple-Negative Breast Cancer

Registered drugNo placebo

Study of Bicalutamide and Abemaciclib for Patients with Advanced Androgen Receptor Positive Triple-Negative Breast Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Abemaciclib
Sponsor:UZ Leuven

Contact Research Centre

Rheumatoid arthritis

Recruiting

Study on Reducing Rituximab Dosage for Patients with Rheumatoid Arthritis

Registered drugNo placebo

Study on Reducing Rituximab Dosage for Patients with Rheumatoid Arthritis

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Rituximab
Sponsor:UZ Leuven

Contact Research Centre

Breast cancer metastatic

Recruiting

Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

InvestigationalNo placebo

Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Abemaciclib
Sponsor:Leonabio Inc.

Contact Research Centre

Non-small cell lung cancer

Recruiting

Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

Registered drugNo placebo

Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Docetaxel
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in La Louviere

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on lymphomas and blood cancers, including studies evaluating novel therapies for diffuse large B-cell lymphoma and multiple myeloma. Clinical trials are investigating combination treatments and maintenance therapies to improve patient outcomes.

DLBCL Treatment Studies
Multiple Myeloma Therapies
Chronic Lymphocytic Leukemia

02 Solid Tumors

Comprehensive research into various solid cancers, with emphasis on non-small cell lung cancer, breast cancer, and colorectal cancer. Studies are exploring targeted therapies and immunotherapy approaches for better treatment outcomes.

Prostate Cancer Treatments
Triple-Negative Breast Cancer
Advanced Lung Cancer Therapies

03 Chronic Conditions

Studies addressing long-term health conditions, including severe asthma and hepatitis B. Research focuses on treatment optimization and understanding patient responses to various therapeutic approaches.

Asthma Management
Hepatitis Treatment
Cardiovascular Disease Prevention

Back to Belgium All countries